Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up.

Source:http://linkedlifedata.com/resource/pubmed/id/20135347

Download in:

View as

General Info

PMID
20135347